Virus-like Particles Market Analysis and Forecast 2028

    Virus-Like Particles Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Hepatitis, Cancer, Others); Source (Yeast, Insect cells, Others); Application (Vaccine, and Therapeutics and Imaging Agents)

    Publication Month: Nov 2021 | Report Code: TIPRE00025763 | No. of Pages: 163 | Category: Biotechnology | Status: Published

    The virus-like particles (VLP’s) market is projected to reach US$ 7,858.82 million by 2028 from US$ 4,601.84 million in 2021; it is expected to grow at a CAGR of 7.9% from 2021 to 2028.

    The commercialization of virus-like particles -based vaccines against human and animal viruses, vigorous research and development activities for the development of virus-like particles -based viral vaccines, and virus-like particles emerging as a reliable immunotherapy platform for allergic diseases are the key driving factors responsible for the overall market growth. However, technical challenges related to the design, purification, and storage of eVLPs impede the overall market growth. Additionally, complexities associated with the manufacturing of virus-like particles vaccines, coupled with excess cost and time requirement of processes (such as downstream processing for virus-like particles -based vaccines), further limit the global market growth. Furthermore, virus-like particles -based therapeutics intended for topical and emerging viral diseases as well as cancer are still under development, which is posing lucrative opportunities for the overall market growth.

    Strategic Insights


    North America is likely to continue its dominance in the virus-like particles market during 2021–2028. The US holds the largest share of the market in North American and is expected to continue this trend during the forecast period. This is primarily attributed to commonly observed susceptibility of people toward viral infections, such as viral influenza caused by different variants. Moreover, continuous R&D activities required for the manufacturing of live attenuated vaccines compels biopharmaceutical companies to opt for virus-like particle’s, which further supports the market growth.

    Lucrative Regions for Virus-Like Particles (VLPs) Market

    Lucrative Regions for Virus-Like Particles (VLPs) Market

    Get more information on this report :


    Market Insights

    Commercialized virus-like particles based Vaccines drives the overall market growth

    According to a report published by the Frontiers Media S.A., the first virus-like particles -based vaccine was designed to combat a deadly virus, Hepatitis B, and virus-like particles -based vaccines have produced promising safety results compared to traditional vaccines. The first commercialized virus-like particles -based vaccine was against HBV. Also, the commercial anti-HBV vaccines, namely, "Engerix" manufactured by GlaxoSmithKline and "Recombivax HB" manufactured by Merck & Co. were approved in 1980, and they were all virus-like particles. The next commercially available virus-like particles -based vaccine was "Gardasil," which was approved in 2006 to prevent human papillomavirus (HPV) infections. Further, virus-like particles are also used in veterinary medicine. The first commercially available veterinary vaccine based on virus-like particles was proven effective against porcine circovirus type 2 (PCV2).

    The role of virus-like particles in the development of immunotherapy products against allergic diseases further stimulates the overall market growth. virus-like particles are used in the treatment of allergic rhinitis, asthma, and dust mite reactions. The aforementioned factors drive the growth of the overall virus-like particles market exponentially. virus-like particles vaccines have shown rapid immune response with mild skin reaction as side effects.

    Product Type-Based Insights

    Based on product type, the virus-like particles market is segmented as hepatitis, cancer/HPV, and Gaucher disease. The hepatitis segment would account for a large market share during 2021–2028. The Frontiers S.A. report pinpoints that hepatitis C virus (HCV) infects 2% of the global population, and it is a leading cause of liver disease and liver transplantation. This medical threat can partially be addressed by the introduction of new antiviral therapies. For example, a vaccine with 50–80% efficacy, targeting high-risk intravenous drug users, dramatically reduces HCV incidence among the population. Therefore, virus-like particles represent a safe and highly immunogenic vaccine delivery platform that induces an adaptive immune response. Several virus-like particles -based vaccines are currently in clinical trials; however, licensed VLP vaccines for HBV and HPV have been in use since long. Thus, virus-like particles based vaccines have proved their effectiveness relating to favorable immunological characteristics and making them one of the promising HCV vaccines.

    Virus-Like Particles (VLPs) Market, by Product Type – 2020 and 2028

    Virus-Like Particles (VLPs) Market, by Product Type – 2020 and 2028

    Get more information on this report :


    Source-Based Insights

    Based on source, the virus-like particles (VLP’s) market is segmented into yeast, insect cell, plant, and others. The yeast segment holds a considerable market share and is projected to continue the similar trend during the forecast period. virus-like particles are produced by heterologous expression systems, involving yeast or baculovirus, as well as plants and bacteria. Safety of virus-like particles -based vaccines produced using yeast expression systems contributes to the growth of the market for the yeast-based virus-like particles.

    Application -Based Insights

    By application, the virus-like particles market is segmented as vaccines and therapeutics. The vaccines segment would hold a considerable share of the market in 2021, and it is likely to continue its dominance in the market during the forecast period as well. Vaccination is considered as one of the most effective ways of controlling pathogens and preventing diseases, both in humans and animals. virus-like particles -based vaccines represent one of the most appealing approaches owing to their intrinsic immunogenic properties and safety. For example, virus-like particles are noninfectious, multimeric antigens having a particulate structure, suitable for the induction of safe and efficient humoral and cellular immune response. Apart from that, virus-like particles vaccines have proved their effectiveness in veterinary field. virus-like particles are only composed of one or more structural proteins without presence of genomes of native viruses and non-ability for self-replication in cells. However, virus-like particles containing either monovalent or multivalent antigen can be produced in compliance with the requirement for serological surveillance, the utility of virus-like particles vaccines proves promising in the veterinary field. One such example of utilizing virus-like particles vaccines under Differentiating Infected from Vaccinated Animals (DIVA) vaccination strategies against animal diseases.

    Companies operating in the virus-like particles (VLPs) market adopt the product innovation strategy to meet the evolving customer demands across the world, which also permits them to maintain their brand name in the global market.

    Virus-Like Particles (VLPs) Market – by Product Type

    • Hepatitis
    • Cancer/HPV
    • Gaucher Disease

    Virus-Like Particles (VLPs) Market – by Source

    • Yeast
    • Insect Cell
    • Plant
    • Others

    Virus-Like Particles (VLPs) Market – by Application

    • Vaccines
    • Therapeutics

    Virus-Like Particles (VLPs) Market – by Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • UK
      • Spain
      • Rest of Europe
    • Asia Pacific (APAC)
      • China
      • India
      • South Korea
      • Japan
      • Australia
      • Rest of APAC
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA
    • South and Central America (SCAM)
      • Brazil
      • Argentina
      • Rest of SCAM

    Company Profiles

    • Merck & Co., Inc.
    • GlaxoSmithKline plc.
    • Pfizer Inc.
    • Dynavax Technologies
    • Sanofi
    • Wantai BioPharm
    • Serum Institute of India Pvt. Ltd.
    • BHARAT BIOTECH
    • LG Chem
    • VBI Vaccines Inc.

    Frequently Asked Questions

    Global virus-like particles (VLP's) market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In North America, the U.S. is the largest market for virus-like particles (VLP’s). The US is estimated to hold the largest share in the virus-like particles (VLP’s) market during the forecast period. Presence of top players and favorable regulations related to product approvals coupled with commercializing new products are the contributing factors for the regional growth. Additionally, increasing number of R&D activities is the key factor responsible for the Asia-Pacific regional growth for VLP’s accounting fastest growth of the region during the coming years.
    Answer: - Merck & Co., Inc., GlaxoSmithKline plc., Pfizer Inc., Dynavax Technologies, Sanofi, Wantai BioPharm, Serum Institute of India Pvt. Ltd., BHARAT BIOTECH, LG Chem, and VBI Vaccines Inc. are among the leading companies operating in the global Virus-Like Particles (VLP's) market
    The vaccine segment dominated the global virus-like particles (VLP's) market and accounted for the largest revenue of 4,558.08 Mn in 2021.
    Based on product-type, hepatitis segment took the forefront lead in the worldwide market by accounting largest share in 2020 and is expected to continue to do so till the forecast period.
    American Society for Microbiology defines virus-like particles (VLP's) as non-infectious multiprotein structure that are engineered to self-assemble from viral structure proteins. VLP technology proves to be a very powerful tool involved in development of vaccines. Several VLP based vaccines exist in the global market involving hepatitis B virus and human papillomavirus.
    Commercial VLP based vaccines against human and animal viruses, intensive research and development activities for the development of VLPs based vaccines effective against viral infections, and VLPs acting as the best immunotherapy platform for allergic diseases are the key driving factors responsible for the overall market growth.

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Virus-like Particles Market – By Product Type

    1.3.2 Global Virus-like Particles Market – By Source

    1.3.3 Global Virus-like Particles Market – By Application

    1.3.4 Global Virus-like Particles Market – By Geography

    2. Global Virus-like Particles Market – Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Virus-like Particles Market– Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America – PEST Analysis

    4.2.2 Europe – PEST Analysis

    4.2.3 Asia Pacific – PEST Analysis

    4.2.4 Middle East and Africa – PEST Analysis

    4.2.5 South and Central America (SCAM) – PEST Analysis

    4.3 Experts Opinion

    5. Virus-like Particles Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Prevalence of Infectious Viral Diseases

    5.1.2 Widening Role of Virus-Like Particles in Therapeutic Developments and Studies

    5.2 Market Restraints

    5.2.1 Availability of Alternative Technologies for Viral Vaccine Production

    5.3 Market Opportunities

    5.3.1 Potential Applications in Therapeutics and Diagnostics

    5.4 Future Trends

    5.4.1 Continuous Demand for Innovative and Effective Products

    5.5 Impact Analysis

    6. Virus-like Particles Market– Global Analysis

    6.1 Global Virus-like Particles Market Revenue Forecast and Analysis

    6.2 Global Virus-like Particles Market, By Geography - Forecast and Analysis

    7. Virus-like Particles Market Revenue and Forecasts To 2028– by Product Type

    7.1 Overview

    7.2 Global Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

    7.3 Hepatitis

    7.3.1 Overview

    7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    7.4 Cancer/ Human Papillomavirus (HPV)

    7.4.1 Overview

    7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    7.5 Gaucher Disease

    7.5.1 Overview

    7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    8. Virus-like Particles Market Revenue and Forecasts To 2028 – By Source

    8.1 Overview

    8.2 Global Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

    8.3 Yeast

    8.3.1 Overview

    8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    8.4 Plant

    8.4.1 Overview

    8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    8.5 Insect Cell

    8.5.1 Overview

    8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    8.6 Others

    8.6.1 Overview

    8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    9. Virus-like Particles Market Revenue and Forecasts To 2028 – By Application

    9.1 Overview

    9.2 Global Virus-like Particles Market Share, by Treatment, 2021 & 2028 (%)

    9.3 Vaccines

    9.3.1 Overview

    9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    9.4 Therapeutics

    9.4.1 Overview

    9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10. Virus-like Particles Market Revenue and Forecasts to 2028 – Geographical Analysis

    10.1 North America: Virus-like Particles Market

    10.1.1 Overview

    10.1.2 North America: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.3 North America: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)

    10.1.4 North America Virus-Like Particles Market, by Source, 2019–2028 (US$ Mn)

    10.1.5 North America: Virus-like Particles Market, by Application, 2019–2028 (US$ Mn)

    10.1.6 North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)

    10.1.6.1 US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.6.1.1 Overview

    10.1.6.1.2 US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.6.1.3 US: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)

    10.1.6.1.4 US: Virus-like Particles Market, by Source, 2019–2028 (US$ Mn)

    10.1.6.1.5 US: Virus-like Particles Market, by Application, 2019–2028 (US$ Mn)

    10.1.6.2 Canada: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.6.2.1 Overview

    10.1.6.2.2 Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.6.2.3 Canada: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)

    10.1.6.2.4 Canada: Virus-like Particles Market, by Source, 2019–2028 (US$ Mn)

    10.1.6.2.5 Canada Virus-Like Particles Market, by Application, 2019–2028 (US$ Mn)

    10.1.6.3 Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.6.3.1 Overview

    10.1.6.3.2 Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.1.6.3.3 Mexico: Virus-like Particles Market, by Product Type, 2019–2028 (US$ Mn)

    10.1.6.3.4 Mexico: Virus-like Particles Market, by Source, 2019–2028 (US$ Mn)

    10.1.6.3.5 Mexico: Virus-like Particles Market, by Application, 2019–2028 (US$ Mn)

    10.2 Europe: Virus-like Particles Market

    10.2.1 Overview

    10.2.2 Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.3 Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.4 Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.5 Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.2.6 Europe: Virus-like Particles Market, by Country, 2021 & 2028(%)

    10.2.6.1 Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.1.1 Overview

    10.2.6.1.2 Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.1.3 Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.1.4 Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.1.5 Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.2 France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.2.1 Overview

    10.2.6.2.2 France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.2.3 France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.2.4 France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.2.5 France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.3 UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.3.1 Overview

    10.2.6.3.2 UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.3.3 UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.3.4 UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.3.5 UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.4 Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.4.1 Overview

    10.2.6.4.2 Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.4.3 Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.4.4 Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.4.5 Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.5 Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.5.1 Overview

    10.2.6.5.2 Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.5.3 Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.5.4 Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.5.5 Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.6 Rest of Europe: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.6.1 Overview

    10.2.6.6.2 Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.6.3 Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.6.4 Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    10.2.6.6.5 Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3 Asia Pacific Virus-like Particles Market Revenue and Forecasts To 2028

    10.3.1 Overview

    10.3.2 Asia Pacific Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.3 Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.4 Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.3.5 Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

    10.3.6.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.1.1 Overview

    10.3.6.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)

    10.3.6.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)

    10.3.6.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.2.1 Overview

    10.3.6.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)

    10.3.6.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.3.1 Overview

    10.3.6.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.4.1 Overview

    10.3.6.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.5.1 Overview

    10.3.6.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.6.1 Overview

    10.3.6.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.3.6.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4 Middle East & Africa Virus-like Particles Market Revenue and Forecasts To 2028

    10.4.1 Overview

    10.4.2 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.3 Middle East & Africa: Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)

    10.4.4 Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.4.5 Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6 Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

    10.4.6.1 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.1.1 Overview

    10.4.6.1.2 UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.1.3 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.1.4 UAE: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)

    10.4.6.1.5 UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.2.1 Overview

    10.4.6.2.2 Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.2.3 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.2.4 Saudi Arabia: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)

    10.4.6.2.5 Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.3 South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.3.1 Overview

    10.4.6.3.2 South Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.3.3 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.3.4 South Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)

    10.4.6.3.5 South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.4 Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.4.1 Overview

    10.4.6.4.2 Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.4.3 Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.4.6.4.4 Rest of Middle East & Africa: Virus-like Particles Market Revenue and Forecasts To 2028, by Source (US$ Mn)

    10.4.6.4.5 Rest of Middle East and Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.5 South and Central America Virus-like Particles Market Revenue and Forecasts To 2028

    10.5.1 Overview

    10.5.2 South and Central America Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.3 South and Central America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    10.5.4 South and Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    10.5.5 South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.5.6 South and Central America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

    10.5.6.1 Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.6.1.1 Overview

    10.5.6.1.2 Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.6.1.3 Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.1.4 Brazil Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Mn)

    10.5.6.1.5 Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.2 Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.6.2.1 Overview

    10.5.6.2.2 Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    10.5.6.2.3 Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.2.4 Argentina: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Mn)

    10.5.6.2.5 Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.3 Rest of South and Central America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.3.1 Overview

    10.5.6.3.2 Rest of South and Central America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.3.3 Rest of South & Central America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    10.5.6.3.4 Rest of South & Central America: Virus-like Particles Market, by Source - Revenue and Forecasts To 2028 (US$ Mn)

    10.5.6.3.5 Rest of South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    11. Impact Of COVID-19 Pandemic on Virus-like Particles Market

    11.1 North America: Impact Assessment of COVID-19 Pandemic

    11.2 Europe: Impact Assessment of COVID-19 Pandemic

    11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

    11.4 South And Central America: Impact Assessment of COVID-19 Pandemic

    11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    12. Virus-like Particles Market–Industry Landscape

    12.1 Overview

    12.2 Growth Strategies Done by the Companies in the Market, (%)

    12.3 Organic Developments

    12.3.1 Overview

    12.4 Inorganic Developments

    12.4.1 Overview

    13. Company Profiles

    13.1 Merck & Co., Inc.

    13.1.1 Key Facts

    13.1.2 Business Description

    13.1.3 Products and Services

    13.1.4 Financial Overview

    13.1.5 SWOT Analysis

    13.1.6 Key Developments

    13.2 GlaxoSmithKline plc.

    13.2.1 Key Facts

    13.2.2 Business Description

    13.2.3 Products and Services

    13.2.4 Financial Overview

    13.2.5 SWOT Analysis

    13.2.6 Key Developments

    13.3 Pfizer Inc.

    13.3.1 Key Facts

    13.3.2 Business Description

    13.3.3 Products and Services

    13.3.4 Financial Overview

    13.3.5 SWOT Analysis

    13.3.6 Key Developments

    13.4 Dynavax Technologies

    13.4.1 Key Facts

    13.4.2 Business Description

    13.4.3 Products and Services

    13.4.4 Financial Overview

    13.4.5 SWOT Analysis

    13.4.6 Key Developments

    13.5 Sanofi

    13.5.1 Key Facts

    13.5.2 Business Description

    13.5.3 Products and Services

    13.5.4 Financial Overview

    13.5.5 SWOT Analysis

    13.5.6 Key Developments

    13.6 Wantai BioPharm

    13.6.1 Key Facts

    13.6.2 Business Description

    13.6.3 Products and Services

    13.6.4 Financial Overview

    13.6.5 SWOT Analysis

    13.6.6 Key Developments

    13.7 Serum Institute of India Pvt. Ltd.

    13.7.1 Key Facts

    13.7.2 Business Description

    13.7.3 Products and Services

    13.7.4 Financial Overview

    13.7.5 SWOT Analysis

    13.7.6 Key Developments

    13.8 BHARAT BIOTECH

    13.8.1 Key Facts

    13.8.2 Business Description

    13.8.3 Products and Services

    13.8.4 Financial Overview

    13.8.5 SWOT Analysis

    13.8.6 Key Developments

    13.9 LG Chem

    13.9.1 Key Facts

    13.9.2 Business Description

    13.9.3 Products and Services

    13.9.4 Financial Overview

    13.9.5 SWOT Analysis

    13.9.6 Key Developments

    13.10 VBI Vaccines Inc.

    13.10.1 Key Facts

    13.10.2 Business Description

    13.10.3 Products and Services

    13.10.4 Financial Overview

    13.10.5 SWOT Analysis

    13.10.6 Key Developments

    14. Appendix

    14.1 About The Insight Partners

    14.2 Glossary of Terms


    LIST OF TABLES

    Table 1. North America Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 2. North America Virus-Like Particles Market, by Source– Revenue and Forecast to 2028 (USD Million)

    Table 3. North America Virus-like Particles Market, by Application– Revenue and Forecast to 2028 (US$ Mn)

    Table 4. US Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 5. US Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 6. US Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 7. Canada: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 8. Canada Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 9. Canada Virus-Like Particles Market, by Application – Revenue and Forecast to 2028 (US$ Mn)

    Table 10. Mexico: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 11. Mexico Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 12. Mexico Virus-like Particles Market Revenue and Forecasts to 2028, by Application (US$ Mn)

    Table 13. Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 14. Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 15. Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 16. Germany: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 17. Germany: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 18. Germany Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 19. France: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 20. France: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 21. France Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 22. UK: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 23. UK: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 24. UK Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 25. Italy: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 26. Italy: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 27. Italy Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 28. Spain: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 29. Spain: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 30. Spain Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 31. Rest of Europe: Virus-like Particles Market, by Product Type – Revenue and Forecast to 2028 (US$ Mn)

    Table 32. Rest of Europe: Virus-like Particles Market, by Source– Revenue and Forecast to 2028 (US$ Mn)

    Table 33. Rest of Europe Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 34. Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn).

    Table 35. Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 36. Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 37. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)

    Table 38. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)

    Table 39. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 40. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 41. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Mn)

    Table 42. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 43. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 44. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 45. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 46. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 47. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 48. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 49. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 50. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 51. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 52. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 53. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 54. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 55. Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 56. Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 57. Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 58. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 59. UAE Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 60. UAE Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 61. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 62. Saudi Arabia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 63. Saudi Arabia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 64. South Africa Virus-like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Mn)

    Table 65. South Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 66. South Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 67. Rest of Middle East & Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 68. Rest of Middle East & Africa Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 69. Rest of Middle East and Africa Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 70. South and Central America Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    Table 71. South and Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 72. South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 73. Brazil: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    Table 74. Brazil Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 75. Brazil Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 76. Argentina: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    Table 77. Argentina: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 78. Argentina Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 79. Rest of South & Central America: Virus-like Particles Market, by Product Type - Revenue and Forecast to 2028 (US$ Mn)

    Table 80. Rest of South & Central America: Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Mn)

    Table 81. Rest of South and Central America Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Mn)

    Table 82. Organic Developments Done by Companies

    Table 83. Inorganic Developments Done by Companies

    Table 84. Glossary of Terms: Virus-like Particles Market


    LIST OF FIGURES

    Figure 1. Virus-like particles Market Segmentation

    Figure 2. Virus-like particles Market Segmentation, By Region

    Figure 3. Global Virus-like Particles Market Overview

    Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Virus-like particles Market

    Figure 5. Asia Pacific to Show Significant Growth during Forecast Period

    Figure 6. Virus-like Particles Market, by Geography (US$ Mn)

    Figure 7. Global Virus-like Particles Market – Leading Country Markets (US$ Mn)

    Figure 8. Global Virus-like Particles Market, Industry Landscape

    Figure 9. North America PEST Analysis

    Figure 10. Europe PEST Analysis

    Figure 11. Asia Pacific PEST Analysis

    Figure 12. Middle East and Africa PEST Analysis

    Figure 13. South and Central America (SCAM) PEST Analysis

    Figure 14. Virus-like Particles Market: Impact Analysis of Drivers and Restraints

    Figure 15. Global Virus-like Particles Market– Revenue Forecast and Analysis – 2020- 2028

    Figure 16. Global Virus-like Particles Market – By Geography Forecast and Analysis – 2021- 2028

    Figure 17. Global Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

    Figure 18. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 19. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 20. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 21. Global Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

    Figure 22. Yeast: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 23. Plant: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 24. Insect Cell: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 25. Others: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 26. Global Virus-like Particles Market Share, by Treatment, 2021 & 2028 (%)

    Figure 27. Vaccine: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 28. Therapeutics: Virus-like Particles Market Revenue and Forecasts To 2028 (US$ Mn)

    Figure 29. North America: Virus-like Particles Market, by Key Country – Revenue (2021) (US$ Mn)

    Figure 30. North America Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 31. North America: Virus-like Particles Market, by Country, 2021 & 2028 (%)

    Figure 32. US: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 33. Canada: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 34. Mexico: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 35. Europe: Virus-like Particles Market, by Key Country – Revenue (2021) (USD Million)

    Figure 36. Europe: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 37. Europe: Virus-like Particles Market, by Country, 2021 & 2028 (%)

    Figure 38. Germany: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 39. France: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 40. UK: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 41. Italy: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 42. Spain: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 43. Rest of Europe: Virus-like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 44. Asia Pacific Virus-like Particles Market Overview, by Country (2021)

    Figure 45. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 46. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

    Figure 47. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 48. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 49. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 50. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 51. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 52. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Mn)

    Figure 53. Middle East & Africa Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Mn)

    Figure 54. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 55. Middle East & Africa Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

    Figure 56. UAE: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 57. Saudi Arabia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 58. South Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 59. Rest of Middle East and Africa: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Mn)

    Figure 60. South and Central America Virus-like Particles Market Revenue Overview, by Country, 2021 (US$ Mn)

    Figure 61. South and Central America Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 62. South and Central America Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

    Figure 63. Brazil: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 64. Argentina Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Mn)

    Figure 65. Rest of South and Central America: Virus-like Particles Market– Revenue and Forecast to 2028 (US$ Mn)

    Figure 66. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 67. Impact of COVID-19 Pandemic in European Country Markets

    Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 69. Impact Of COVID-19 Pandemic in South and Central America Country Markets

    Figure 70. Impact Of COVID-19 Pandemic in South and Central America Country Markets

    Figure 71. Growth Strategies Done by the Companies in the Market, (%)

    The List of Companies - Virus-like Particles (VLP's) Market

    1. Merck & Co., Inc.
    2. GlaxoSmithKline plc.
    3. Pfizer Inc.
    4. Dynavax Technologies
    5. Sanofi
    6. Wantai BioPharm
    7. Serum Institute of India Pvt. Ltd.
    8. BHARAT BIOTECH
    9. LG Chem
    10. VBI Vaccines Inc.
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the virus-like particles (VLP’s) market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global virus-like particles (VLP’s) market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.  
    TIPRE00025763
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market




    Have a question?

    Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


    Speak To Analyst
    Pricing
    • $3000
    • $4550
    • $6550
    • $8550
        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount